Myeloma cast nephropathy (MGRS)

From Magnesium
Revision as of 23:56, 29 January 2024 by Ossip Groth (talk | contribs) (Created page with "{{tp|p=28508984|t=2016. Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.|pdf=|usr=}}{{28508984}} {{tp|p=35592304|t=2022. Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.|pdf=|usr=}}{{35592304}} {{tp|p=22484811|t=2012. Treating myeloma cast nephropathy without treating myeloma.|pdf=|usr=}}{{22484811}}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


28508984 PDF 2016. Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.Template:28508984
35592304 PDF 2022. Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.Template:35592304
22484811 PDF 2012. Treating myeloma cast nephropathy without treating myeloma.Template:22484811

Retrieved from "http://mg.moremed.org:80/w/index.php?title=Myeloma_cast_nephropathy_(MGRS)&oldid=187"